Bio-Works Technologies Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Public

  • Employees
  • 34

Employees

  • Stock Symbol
  • BIOWKS

Stock Symbol

  • Share Price
  • $0.22
  • (As of Friday Closing)

Bio-Works Technologies General Information

Description

Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Commercial Services
Stock Exchange
STO
Corporate Office
  • Virdings allé 18
  • 754 50 Uppsala
  • Sweden
+46 08-562 000 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bio-Works Technologies Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.22 $0.25 $0.21 - $1.61 $8.55M 39M 32.5K -$0.15

Bio-Works Technologies Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 21,378 21,378 62,181 100,912
Revenue 4,130 4,130 4,073 2,551
EBITDA (5,175) (5,175) (4,391) (1,009)
Net Income (5,346) (5,346) (4,431) (1,507)
Total Assets 6,219 6,219 8,782 13,355
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bio-Works Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bio-Works Technologies‘s full profile, request access.

Request a free trial

Bio-Works Technologies Patents

Bio-Works Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2625142-A1 Method for removing arsenic from water using polymer based matrices with chelating groups comprising metal ions Inactive 05-Oct-2010 000000000 0
US-20130186836-A1 Method for removing arsenic from water using polymer based matrices with chelating groups comprising metal ions Inactive 05-Oct-2010 000000000 0
EP-2625142-A4 Method for removing arsenic from water using polymer based matrices with chelating groups comprising metal ions Inactive 05-Oct-2010 000000000 0
ES-2586613-T3 Method for the manufacture of agarose gels Active 04-May-2007 00000000000
US-9045566-B2 Method for the manufacture of agarose gels Active 04-May-2007 C08B37/0039 00
To view Bio-Works Technologies’s complete patent history, request access »

Bio-Works Technologies Executive Team (12)

Name Title Board Seat Contact Info
Jonathan Royce Chief Executive Officer
Arne Hauge Chief Financial Officer
Allan Simpson Co-Chief Operating Officer
Karsten Fjarstedt Co-Chief Operating Officer
Anna Lindqvist Chief Marketing Officer
You’re viewing 5 of 12 executive team members. Get the full list »

Bio-Works Technologies Board Members (9)

Name Representing Role Since
Kirsti Gjellan Ph.D Bio-Works Technologies Board Member 000 0000
Patrick van de Velde Self Board Member 000 0000
Peo Crona Self Board Member 000 0000
Peter Ehrenheim Self Chairman of the Board 000 0000
Peter Nahlstedt Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Bio-Works Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bio-Works Technologies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bio-Works Technologies‘s full profile, request access.

Request a free trial

Bio-Works Technologies Subsidiaries (1)

Company Name Industry Location Founded
Bio-Works Sweden Biotechnology Uppsala, Sweden 0000
To view Bio-Works Technologies’s complete subsidiaries history, request access »

Bio-Works Technologies FAQs

  • When was Bio-Works Technologies founded?

    Bio-Works Technologies was founded in 2006.

  • Who is the founder of Bio-Works Technologies?

    Jan Berglof, Göran Lindgren, and John Connolly are the founders of Bio-Works Technologies.

  • Who is the CEO of Bio-Works Technologies?

    Jonathan Royce is the CEO of Bio-Works Technologies.

  • Where is Bio-Works Technologies headquartered?

    Bio-Works Technologies is headquartered in Uppsala, Sweden.

  • What is the size of Bio-Works Technologies?

    Bio-Works Technologies has 34 total employees.

  • What industry is Bio-Works Technologies in?

    Bio-Works Technologies’s primary industry is Biotechnology.

  • Is Bio-Works Technologies a private or public company?

    Bio-Works Technologies is a Public company.

  • What is Bio-Works Technologies’s stock symbol?

    The ticker symbol for Bio-Works Technologies is BIOWKS.

  • What is the current stock price of Bio-Works Technologies?

    As of 17-May-2024 the stock price of Bio-Works Technologies is $0.22.

  • What is the current market cap of Bio-Works Technologies?

    The current market capitalization of Bio-Works Technologies is $8.55M.

  • What is Bio-Works Technologies’s current revenue?

    The trailing twelve month revenue for Bio-Works Technologies is $4.13M.

  • What is Bio-Works Technologies’s annual earnings per share (EPS)?

    Bio-Works Technologies’s EPS for 12 months was -$0.15.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »